Supporting national immunization technical advisory groups (NITAGs) in resource-constrained settings. New strategies and lessons learned from the Task Force for Global Health's Partnership for influenza vaccine introduction
Supporting national immunization technical advisory groups (NITAGs) in resource-constrained settings. New strategies and lessons learned from the Task Force for Global Health's Partnership for influenza vaccine introduction
复制标题
DOI：
10.1016/j.vaccine.2019.05.046
复制
发表时间：
2019-06-19
期刊：
影响因子：
5.5
通讯作者：
Seward, Jane F.
中科院分区：
文献类型：
--
作者：
Ba-Nguz, Antoinette;Shah, Adeel;Seward, Jane F.
国家免疫技术咨询小组（NITAG）是多学科的国家专家，他们向国家卫生当局提供独立的，循证的疫苗政策建议。NITAG的一个基本职能是确保这些决定基于通过系统、透明的过程产生的最佳可用证据。然而，在许多低收入和中等收入国家，这种决策方法的经验有限。全球卫生工作队与疾病控制和预防中心、卫生部、企业合作伙伴和其他机构合作，管理流感疫苗引进伙伴关系（PIVI）计划。2017年，PIVI与其国家合作伙伴和世界卫生组织区域和地方办事处合作，评估NITAG加强需求，并在7个LMIC国家（老挝人民民主共和国，蒙古，越南，亚美尼亚，科特迪瓦;摩尔多瓦和格鲁吉亚共和国）提供技术援助。我们的研讨会支持NITAG的一般能力建设和使用该国感兴趣的疫苗的循证审查过程。对于审查季节性流感证据的NITAG，我们开发了一个流感资源包，以支持他们的审查，并以易于使用的格式提供国家相关信息。在接受培训的七名NITAG中，有六名应用了所学到的一些概念：修订或制定正式、透明、系统的操作程序;使用来自系统搜索和本地数据的质量评估数据制定季节性流感疫苗接种建议;并应用了所学到的原则来制定其他新疫苗建议。我们的经验证实，LMIC NITAG资源严重不足，没有足够的技术支持或获得全球同行评审文献。必须确保NITAG合作伙伴的持续支持，可能需要创造性的方法来帮助各国实现GVAP 2020目标，并支持制定可持续的疫苗政策和计划。(C)2019由Elsevier Ltd.出版
National Immunization Technical Advisory Groups (NITAGs) are multidisciplinary national experts who provide independent, evidence-informed vaccine policy recommendations to national health authorities. An essential NITAG function is to ensure that these decisions are grounded in the best available evidence generated through a systematic, transparent process. However, in many low- and middle-income countries (LMICs), experience with this decision making method is limited. The Task Force for Global Health manages the Partnership for Influenza Vaccine Introduction (PIVI) program in collaboration with the Centers for Disease Control and Prevention, Ministries of Health, corporate partners and others. During 2017, PIVI worked with its country partners and the World Health Organization regional and local offices to assess NITAG strengthening needs and to provide technical assistance in 7 LMIC countries (Laos Peoples Democratic Republic, Mongolia, Vietnam, Armenia, Cote d'Ivoire; Moldova and the Republic of Georgia). Our workshops supported general NITAG capacity building and the evidence-based review process using vaccines of interest to the country. For NITAGs reviewing evidence on seasonal influenza, we developed an influenza resource package to support their review and provide country-relevant information in an easy to use format. Of the seven NITAGs trained, six have applied some of the concepts learnt: revision or development of formal transparent, systematic procedures for their operations; preparation of recommendations on seasonal influenza vaccination using quality-assessed data from systematic searches and local data; and have applied the principles learned for making other new vaccine recommendations. Our experience confirms that LMIC NITAGs are considerably under-resourced without adequate technical support or access to global peer-reviewed literature. Ongoing support from NITAG partners must be secured and creative approaches might be needed to help countries achieve the GVAP 2020 target and support development of sustainable vaccine policies and programs. (C) 2019 Published by Elsevier Ltd.